ArticleOncogene2026

TBKBP1 induces capecitabine resistance through negative regulation of type I interferon pathway in triple-negative breast cancer.

Wen-Ya Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.